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Association between maternal gluten intake and type 1 diabetes 
in offspring: national prospective cohort study in Denmark
Julie C Antvorskov,1 Thorhallur I Halldorsson,2,3,4 Knud Josefsen,1 Jannet Svensson,5  
Charlotta Granström,2 Bart O Roep,6,7 Trine H Olesen,2 Laufey Hrolfsdottir,8 Karsten Buschard,1 
Sjudur F Olsen,2,9
ABSTRACT
Objective
To examine the association between prenatal gluten 
exposure and offspring risk of type 1 diabetes in 
humans.
Design
National prospective cohort study.
setting
National health information registries in Denmark.
ParticiPants
Pregnant Danish women enrolled into the Danish 
National Birth Cohort, between January 1996 and 
October 2002.
Main OutcOMe Measures
Maternal gluten intake, based on maternal 
consumption of gluten containing foods, was reported 
in a 360 item food frequency questionnaire at week 
25 of pregnancy. Information on type 1 diabetes 
occurrence in the participants’ children, from 1 
January 1996 to 31 May 2016, were obtained through 
registry linkage to the Danish Registry of Childhood 
and Adolescent Diabetes.
results
The study comprised 101 042 pregnancies in 
91 745 women, of whom 70 188 filled out the 
food frequency questionnaire. After correcting 
for multiple pregnancies, pregnancies ending in 
abortions, stillbirths, lack of information regarding 
the pregnancy, and pregnancies with implausibly high 
or low energy intake, 67 565 pregnancies (63 529 
women) were included. The average gluten intake 
was 13.0 g/day, ranging from less than 7 g/day to 
more than 20 g/day. The incidence of type 1 diabetes 
among children in the cohort was 0.37% (n=247) 
with a mean follow-up period of 15.6 years (standard 
deviation 1.4). Risk of type 1 diabetes in offspring 
increased proportionally with maternal gluten intake 
during pregnancy (adjusted hazard ratio 1.31 (95% 
confidence interval 1.001 to 1.72) per 10 g/day 
increase of gluten). Women with the highest gluten 
intake versus those with the lowest gluten intake (≥20 
v <7 g/day) had double the risk of type 1 diabetes 
development in their offspring (adjusted hazard ratio 
2.00 (95% confidence interval 1.02 to 4.00)).
cOnclusiOns
High gluten intake by mothers during pregnancy could 
increase the risk of their children developing type 1 
diabetes. However, confirmation of these findings are 
warranted, preferably in an intervention setting.
Introduction
The incidence of type 1 diabetes is highest in countries 
following a western lifestyle,1 and, until recently,2 it has 
been increasing at a rate of 3-4% per year, especially in 
children below 5 years of age in Europe.3 This increase 
is faster than can be accounted for by genetic drift, 
pointing to the importance of environmental factors. 
Gluten proteins found in wheat, rye, and barley are 
believed to be important in diabetes development4; 
they are rich in proline and glutamine,5 which makes 
them highly hydrophobic and partly resistant to 
intestinal degradation. These properties make them 
more immunogenic than other dietary proteins, which 
are efficiently hydrolysed into single amino acids or 
dipeptides or tripeptides.
In an animal model of colitis, wheat gliadin and 
related peptic fragments were shown to activate mouse 
macrophages and human monocytes to produce 
proinflammatory cytokines. This action differed from 
any other food proteins.6 The amino acid sequence of 
wheat gliadin further facilitates the presentation on 
human leucocyte antigen (HLA)-DQ2 and HLA-DQ8.4
The effect of diet on the development of diabetes 
has been consistently shown in animal models of type 
1 diabetes, the BioBreeding rat,7 and the non-obese 
diabetic (NOD) mouse. In NOD mice fed a lifelong 
gluten free diet, we found that incidence of diabetes fell 
from 64% to 15%.8 We then found that dietary gluten 
fed to healthy BALB/c mice changed the cytokine 
pattern in T cells towards an inflammatory cytokine 
profile and increased the proportion of T helper 17 
cells (associated with development of autoimmunity, 
specifically in the pancreatic lymph nodes).9  10 A 
gluten free diet also was shown to induce an anti-
inflammatory profile in NOD mice.9 The incidence 
WhAT IS AlReAdy knoWn on ThIS TopIC
In an animal model of type 1 diabetes, a gluten free maternal diet during 
pregnancy almost completely prevented type 1 diabetes in offspring
However, human studies have not shown an association between maternal 
gluten intake during pregnancy and the risk of type 1 diabetes in offspring
WhAT ThIS STudy AddS
In a study population of 67 565 pregnancies (63 529 women), the incidence of 
type 1 diabetes among children in the cohort was 0.37% (n=247) with a mean 
follow-up period of 15.6 years (standard deviation 1.4)
The risk of type 1 diabetes in offspring increased proportionally with maternal 
gluten intake during pregnancy (adjusted hazard ratio 1.31 (95% confidence 
interval 1.001 to 1.72) per 10 g/day increase of gluten intake)
Mothers with the highest gluten intake versus those with the lowest gluten intake 
(≥20 v <7 g/day) had double the risk of type 1 diabetes development in their 
offspring (adjusted hazard ratio 2.00 (95% confidence interval 1.02 to 4.00))
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of diabetes in the mice offspring was reduced even 
further from 64% to 8% if mothers were fed a gluten 
free diet only during pregnancy.11 This reduction was 
accompanied by an increase in islet number as well as 
decreased insulitis12 in the offspring.
Coeliac disease and type 1 diabetes share the same 
genetic background, with HLA being the predominant 
factor.13 Other common non-HLA loci also confer 
risk to both diseases.14 Coeliac disease is more 
prevalent among children diagnosed with having 
type 1 diabetes,15 and patients with diabetes plus 
unrecognised coeliac disease have an earlier onset 
of type 1 diabetes. If coeliac disease is diagnosed 
first, the risk of an individual developing type 1 
diabetes decreases.16 In addition, the introduction of 
a gluten free diet in patients with a new diagnosis of 
type 1 diabetes diminishes the need for exogenous 
insulin, thereby prolonging the patients’ period of 
remission.17 18
Prenatal exposure to gluten could be relevant to 
type 1 diabetes development, because the process 
leading to islet autoimmunity may begin in fetal life. 
Seroconversion has a peak incidence or median at 
around 9-12 months of age,19–21 and thymic deletion 
of potentially self reactive T cells occurs mainly 
during the prenatal and neonatal periods, suggesting 
that these early stages could be a window for disease 
prevention.22 In two previous studies investigating 
maternal intake of gluten and the development of islet 
autoimmunity in HLA conferred individuals at risk, 
researchers found no association.23  24 The aim of the 
present study was to investigate, in a large prospective 
birth cohort, whether maternal gluten intake is 
associated with the risk of type 1 diabetes in offspring.
Methods
Population and study design
The study was based on data from the Danish National 
Birth Cohort,25 in which pregnant Danish women were 
enrolled from January 1996 to October 2002. Eligible 
individuals were all pregnant women in Demark who 
were fluent in Danish. During the recruitment period, 
91 745 mothers were enrolled, but because women 
were allowed to enter the study more than once, the 
total number of pregnancies was 101 042. Women 
were recruited during their first antenatal visit to the 
general practitioner at 6-10 weeks of pregnancy. The 
study covered about 35% of all births in Denmark 
during the recruitment period. Enrolled women 
participated in two telephone interviews at 12 and 
30 weeks of gestation that collected extensive data on 
maternal lifestyle as well as past and present health 
characteristics. From these interviews, information 
on potential confounders were extracted. In addition, 
a food frequency questionnaire was sent to women 
at about 25 weeks of pregnancy. Familial follow-ups 
were conducted at six and 18 months postpartum, 
when information on breastfeeding was collected. 
Additional follow-ups were conducted when the 
children were 7, 11, and 14 years old. Selection bias for 
the present cohort was evaluated in a previous study, 
which found no difference in associations between 
maternal exposures (such as maternal smoking and 
prepregnancy weight) and preterm delivery and fetal 
growth, among those women recruited and those not 
recruited into the study.26
Outcome measures
Data about the development of type 1 diabetes in the 
children was obtained by unique linkage of person 
specific identifiers (from the Danish Civil Registration 
System (CPR)) to the Danish Registry of Childhood 
and Adolescent Diabetes (DanDiabKids), which covers 
children aged 0-18 years with a diagnosis of type 1 
diabetes. For this study, the register covered diagnoses 
occurring from 1 January 1996 to 31 May 2016. The 
registry is validated annually.3  27 The time of clinical 
diagnosis of type 1 diabetes was set as the first day of 
insulin treatment in accordance with the EURODIAB 
criteria.28 The diagnosis in the DanDiabKids register 
was based on clinical presentation. Any doubt about 
the diagnosis was resolved by autoantibodies, C 
peptide, and genetic testing.
Quantification of gluten intake
Maternal diet was assessed at around week 25 of 
pregnancy by a validated food frequency questionnaire 
of 360 items that covered food intake during the 
previous four weeks.29 Food and nutrient intakes were 
then quantified on the basis of assumptions of standard 
portion sizes and by use of Danish food composition 
tables30  31 containing nutrient information of about 
1030 foods available on the Danish market. If items 
in the questionnaire were not directly covered by 
records in the food composition tables, recipes were 
made with raw ingredients. For foods containing 
gluten, the amount of wheat, rye, and barley could be 
directly calculated for items that were based on recipes 
(bread, crispbread, pasta, lasagne, fast foods, cakes, 
and desserts); these amounts were estimated by expert 
judgments for other items such as beer, meatballs, and 
dumplings. The amount of gluten was then calculated 
on the basis of the protein content of wheat, rye, and 
barley with the conversion factors of 0.80, 0.65, and 
0.50, respectively.32–35 As a quality check, we compared 
our estimated amount of gluten for individual food 
items to comparable work conducted in the Nurses’ 
Health Study.36 Quantified gluten intake based on the 
Harvard data36 strongly correlated with our own intake 
estimates (Spearman’s r~0.95).
cohort attrition
Of 101 042 pregnant women recruited from 1996 to 
2002, 70 188 filled out and returned the food frequency 
questionnaire. Multiple pregnancies (n=1559), 
pregnancies ending in abortions (n=79), stillbirths 
(n=214), or lack of information on these pregnancy 
outcomes (n=96) left 68 240 women available for 
analysis. In our analysis, we also excluded 343 women 
with implausibly high (<25 000 kJ/day) or low (<2500 
kJ/day) energy intake. In addition, we decided a priori 
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to exclude women who had been diagnosed with having 
type 1 diabetes before pregnancy (n=332) to prevent 
potential genetic confounding. These exclusions 
left us with 67 565 pregnancies, corresponding to 
67% of the full cohort and 96% of those women who 
completed the food frequency questionnaire. The 
67 565 pregnancies represented 63 529 individuals, 
because 3992 and 44 women entered the study two 
and three times, respectively. The authors had access 
to the necessary data.
statistical analysis
By use of summary statistics and thorough visual 
inspection, all variables were checked for coding errors 
values that were clearly implausible. Maternal gluten 
intake was categorised by percentiles (<10, 10-20, 20-
50, 50-80, 80-90, ≥90). We then examined maternal 
offspring characteristics across these categories of 
intake using the mean and standard deviation for 
continuous variables and percentages for dichotomous 
variables. With these same categories of exposure, the 
association between maternal gluten intake during 
pregnancy and offspring risk of type 1 diabetes was 
examined by Cox regression. We used offspring age 
from birth up to May 2016 as the underlying timescale 
censoring if death or emigration from Denmark 
occurred (1217 events). Because women could enter 
the study repeatedly through different pregnancies, 
we used a robust sandwich covariance matrix estimate 
to account for interdependent observations. To test 
for linear trend, we used the median intake for each 
of the six gluten categories, entering these values as 
continuous variables in our regression models.
In our analysis, associations were first examined 
by an unadjusted model and then by two adjusted 
models (referred to as models 1 and 2). Characteristics 
that might influence the risk of type 1 diabetes 
were identified a priori and included as potential 
confounders in our adjusted analysis. In model 1, we 
adjusted for: 
•	  Mother’s age at childbirth (<25, 25-35, ≥35 years; 
0.9% (n=58) missing) 
•	  Body mass index before pregnancy (<18.5, 18.5-25, 
25-30, ≥30; 5.8% (n=3924) missing)
•	  Parity (0, 1, <2; 4.4% (n=2946) missing)
•	  Smoking during pregnancy (never, occasional, <15 
cigarettes/day, daily smokers ≥15 cigarettes/day; 
0.7% (n=481) missing)
•	  Parental socioeconomic status (high/intermediate 
level proficiency, skilled worker, unskilled worker/
unemployed, or student; 4.6% (n=3103) missing)
•	  Breastfeeding duration (0, 1, 2, 3, 4, 5, <6 months; 
27.8% (n=18 760) missing)
•	 Caesarean section (yes/no; no missing data)
•	 Offspring sex (male/female; no missing data)
•	  Total energy intake (by quintiles; no missing 
data) was also included to account for potential 
confounding by total energy intake.37
Information on breastfeeding was extracted from the 
telephone interviews conducted at six and 18 months 
postpartum, which had much lower participation 
(72.4%) than the two prenatal interviews where 
information on most covariates was extracted. In model 
2, additional adjustments were made for pre-existing 
maternal type 2 diabetes (no missing) and suspected 
gestational diabetes mellitus cases (no missing).
In our sensitivity analysis, we examined the 
association between maternal gluten intake during 
pregnancy and offspring risk of type 1 diabetes, 
stratifying by maternal age (<30 v ≥30 years), offspring 
sex (boys v girls), maternal body mass index before 
pregnancy (<25 v ≥25), parity (nulliparous v parous), 
and pre-existing diabetes (no diabetes v type 2 
diabetes or gestational diabetes mellitus). Together 
with the stratified results for women with gestational 
diabetes mellitus or type 2 diabetes, the association 
between maternal gluten intake and offspring risk of 
type 1 diabetes was also reported from women with 
underlying type 1 diabetes, although these women 
were a priori excluded from our data. The influence 
of time (offspring age at type 1 diabetes diagnosis) 
was examined in groups, with the end of follow-up 
occurring at 10 years of age on one hand and with 
follow-up starting at 10 years on the other. Computer 
codes are available on request.
Patient and public involvement
The study was conducted on historical data, so we were 
unable to involve patients. We have invited patients to 
help us develop our dissemination strategy.
Results
Mean maternal gluten intake was 13.0 g/day (standard 
deviation 5.3) and a total of 247 (0.37%) offspring with 
type 1 diabetes were identified over a mean follow-up 
period of 15.6 (standard deviation 1.4) years. Women 
in the highest versus lowest category of gluten intake 
(≥20 v <7 g/day, table 1) were more likely to be of 
normal weight (that is, with a body mass index of 
18.5-25; 66.3% v 59.3%), to be non-smoking (75.0% v 
70.0%), to have breastfed their offspring for more than 
one month (65.8% v 59.7%), and to be parous (51.7% 
v 41.9%). In absolute terms, only minor differences 
were observed in familial socio-occupational status 
and other characteristics across categories of increased 
maternal gluten intake. Pre-existing diabetes (type 2 or 
gestational diabetes mellitus) was not related to gluten 
intake.
With respect to maternal diet (table 2), intake of 
both whole and refined grains increased, as expected, 
substantially with higher gluten intake. Women in the 
highest intake category were eating excessive amount 
of grains per day compared with among those in the 
lowest intake category (about 477 g v about 112 g). 
In addition, energy intake increased considerably 
with higher absolute gluten intake, with women in 
the lowest intake category (<7 g/day) having a mean 
energy intake of 7.2 mJ/day compared with 13.6 mJ/
day among women in the highest intake category 
(≥20g/day). However, in terms of nutrient density, the 
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energy coming from protein, carbohydrate, and fat was 
relatively similar across categories of gluten intake.
Maternal gluten intake was significantly associated 
with increased risk of type 1 diabetes in offspring in 
both unadjusted and covariate adjusted analyses (table 
3). Compared with offspring born to mothers with the 
lowest gluten intake (<7 g/day), offspring of those with 
the highest intake (≥20 g/day) had double the risk of 
being diagnosed with having type 1 diabetes during 
follow-up (hazard ratio 2.00 (95% confidence interval 
1.02 to 4.00)). Risk of type 1 diabetes in offspring was 
positively associated with maternal gluten exposure 
during pregnancy: the association was significant 
(Ptrend=0.016) and increased monotonically. Only 
minor differences were observed between the unadjusted 
and covariate adjusted analyses.
In the stratified analyses (table 4), the association 
between maternal gluten intake during pregnancy and 
offspring risk of type 1 diabetes was more pronounced 
among older (age ≥30 years), parous, and overweight 
or obese (body mass index before pregnancy ≥25) 
mothers, with a non-significant but positive increase 
in risk observed in the other groups. A non-significant 
trend was observed between maternal gluten intake 
and offspring risk of type 1 diabetes among the few 
(n=1147, seven cases of type 1 diabetes in offspring) 
women with pre-existing type 2 or gestational diabetes 
mellitus (hazard ratio 2.08 (95% confidence interval 
table 1 | characteristics of study participants (n=67 565) according to gluten intake. Data are mean (standard deviation) for continuous variables and 
number (%) for categorical variables. values presented in table are before imputation of missing values; the number (%) of missing values are given in 
the first column
all participants 
n=67 565
gluten intake by percentile (g/day; median (range))
P*
<10% (5 (0-7); 
n=6756)
10-20% (8 (7-9); 
n=6756)
20-50% (11 (9-
13); n=20 269)
50-80% (14 (13-
17); n=20 270)
50-80% (18 (17-
20); n=6756)
≥90% (22 (20-
66); n=6756)
Maternal characteristics
Maternal age (years)
 <25 5985 (8.9) 932 (13.8) 657 (9.7) 1641 (8.1) 1551 (7.7) 531 (7.9) 673 (10.0) <0.01 
 25-35 26 452 (39.2) 2775 (41.1) 2801 (41.5) 8081 (39.9) 7750 (38.2) 2524 (37.4) 2521 (37.3)
 ≥35 35 070 (51.9) 3046 (45.1) 3294 (48.8) 10 528 (51.9) 10 950 (54.0) 3967 (54.7) 3555 (52.6)
 Missing 58 (0.9) 4 (0.0) 5 (0.1) 19 (0.1) 19 (0.1) 5 (0.1) 7 (0.10)
Body mass index before pregnancy 
 <18.5 2913 (4.3) 266 (3.9) 249 (3.7) 757 (3.7) 924 (4.6) 325 (4.8) 392 (5.8) <0.01 
  18.5-25 43 203 (63.9) 4009 (59.3) 4199 (62.1) 12 810 (63.2) 13 230 (65.3) 4476 (66.2) 4479 (66.3)
 25-30 12 435 (18.4) 1427 (21.1) 1350 (20.0) 3883 (19.2) 3623 (17.9) 1082 (16.1) 1070 (15.8)
 ≥30 5090 (7.5) 589 (8.7) 563 (8.3) 1644 (8.1) 1378 (6.8) 486 (7.2) 430 (6.4)
 Missing 3924 (5.8) 465 (6.9) 396 (5.9) 1175 (5.8) 1115 (5.5) 388 (5.7) 385 (5.7)
Gestational age (days) 280.3 (12.4) 280.0 (12.7) 280.2 (12.6) 280.4 (12.5) 280.5 (12.0) 280.5 (12.0) 280.1 (12.4) 0.10
Preterm pregnancy 2989 (4.4) 323 (4.8) 321 (4.8) 921 (4.5) 830 (4.1) 283 (4.2) 311 (4.6) 0.05
Parity
 0 31 596 (48.9) 3575 (52.9) 3501 (54.0) 9546 (47.1) 10 349 (46.8) 3588 (44.9) 2987 (46.1) <0.01
 ≥1 33 023 (48.9) 2828 (41.9) 2978 (44.1) 9819 (48.4) 9086 (44.8) 2901 (52.7) 3491 (51.7)
 Missing 2946 (4.4) 353 (5.2) 278 (4.1) 904 (4.5) 835 (4.1) 298 (4.4) 278 (4.1)
Smoking during pregnancy
 Non-smoker 50 747 (75.1) 4729 (70.0) 5017 (74.3) 15 336 (75.7) 15 475 (76.3) 5126 (75.9) 5064 (75.0) <0.01 
 Occasional smoker 8253 (12.2) 926 (13.7) 871 (12.9) 2463 (12.2) 2392 (11.8) 795 (11.8) 806 (11.9)
 Daily smoker 8084 (12.0) 1043 (15.4) 818 (12.1) 2311 (11.4) 2284 (11.3) 792 (11.7) 836 (12.5)
 Missing 481 (0.7) 58 (0.9) 51 (0.8) 159 (0.8) 119 (0.6) 44 (0.7) 50 (0.7)
Parental socioeconomic position
 High level proficiency 35 759 (52.9) 3141 (46.5) 3528 (52.2) 10 822 (53.4) 11 075 (54.6) 3665 (54.2) 3528 (52.2) <0.01  
   Medium level  
proficiency
17 547 (26.0) 1900 (28.1) 1844 (27.3) 5338 (26.3) 5083 (25.1) 1702 (25.2) 1680 (24.9)
 Low level proficiency 7752 (11.5) 1003 (14.9) 774 (11.5) 2233 (11.0) 1043 (5.2) 738 (17.0) 431(6.4)
 Students 3404 (5.0) 347 (5.1) 320 (4.7) 926 (4.6) 2185 (10.8) 337 (5.0) 819 (12.1)
 Missing 3103 (4.6) 365 (5.4) 291 (4.3) 950 (4.7) 884 (4.4) 315 (4.7) 298 (4.4)
Months of breastfeeding
 0-1 5362 (7.9) 670 (9.9) 606 (9.0) 1611 (8.0) 1534 (7.6) 478 (7.1) 463 (6.9) <0.01 
 1-6 29 704 (44.0) 1573 (23.3) 2766 (40.9) 8775 (43.3) 9335 (46.1) 3203 (47.4) 3164 (46.8)
 ≥6 13 829 (20.5) 2461 (36.4) 1512 (22.4) 4207 (20.8) 3697 (19.6) 1282 (19.0) 1285 (19.0)
 Missing 18 760 (27.8) 2052 (30.4) 1873 (27.7) 5676 (28.0) 5431 (26.8) 3202 (47.4) 1844 (27.3)
Caesarean section 5362 (15.1) 1071 (15.9) 1115 (16.5) 3141 (15.5) 2899 (14.3) 988 (14.6) 1002 (14.8) <0.01
Suspected gestational 
diabetes mellitus
625 (0.9) 51 (0.8) 53 (0.8) 198 (1.0) 210 (1.0) 56 (0.8) 57 (0.8) 0.15
Type 2 diabetes diag-
nosed before pregnancy
522 (0.8) 50 (0.7) 52 (0.8) 163 (0.8) 153 (0.8) 52 (0.8) 52 (0.8) 0.99
Offspring characteristics
Type 1 diabetes 247 (0.37) 20 (0.30) 20 (0.30) 69 (0.34) 73 (0.36) 30 (0.44) 35 (0.52) 0.18
Age at diagnosis (years) 9.5 (3.9) 10.4 (3.3) 7.5 (3.9) 8.9 (4.0) 10.1 (3.8) 9.8 (4.0) 9.3 (4.1) 0.43
Male 34 658 (51.3) 3470 (51.4) 3532 (52.3) 10 432 (51.5) 10 366 (51.1) 3477 (51.5) 3381 (50.0) 0.20
Birth weight (kg) 3.59 (0.57) 3.54 (0.58) 3.59 (0.57) 3.59 (0.57) 3.60 (0.57) 3.61 (0.57) 3.58 (0.58) <0.01
*P values evaluated by t test for linear trend for continuous variables and χ2 test for categorical variables.
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0.92 to 4.69) per 10 g/day increase in gluten intake). 
Women with no underlying type 2 or gestational 
diabetes mellitus (n=66 418, 240 cases of type 1 
diabetes in offspring) showed a close to significant 
positive trend with gluten intake (hazard ratio 1.27 
(95% confidence interval 0.96 to 1.68) per 10 g/day 
increase in maternal gluten intake). The association 
between maternal gluten intake and type 1 diabetes 
in offspring was more pronounced among male 
offspring. No substantial differences were observed 
when stratifying by offspring age at diagnosis of type 
1 diabetes.
In stability analyses, we firstly examined the 
association between total energy intake in mothers 
and risk of type 1 diabetes in offspring, because 
absolute intake of gluten and total energy intake were 
strongly related (table 2). We saw no association with 
total energy intake and offspring risk of type 1 diabetes 
(Ptrend=0.44, data not shown). When expressing gluten 
intake as energy adjusted residuals37 instead of absolute 
intake as presented in table 2, we also observed a 
significant positive association with risk of type 1 
diabetes in offspring (Ptrend=0.028, table S1). Secondly, 
because we used relatively extreme categories for the 
highest and lowest gluten intake in mothers (<10% 
and ≥90% intake groups), the association with risk of 
type 1 diabetes in offspring using groups of 20% as an 
explanatory variable was also explored (that is, <20%, 
20-40%, 40-60%, 60-80%, ≥80% intake groups; 
table S2). Again, a significant association was observed 
(Ptrend=0.035), although the effect estimates were more 
modest, after collapsing the extreme categories. 
Finally, unadjusted associations were explored 
between women who had one or more covariates 
were missing (n=21 305, 75 cases of type 1 diabetes 
in offspring) and those with complete covariate 
information (n=46 505, 175 cases of type 1 diabetes in 
offspring). When modelling exposure as linear per 10 
g/day increase in gluten intake, without adjusting for 
covariates (in order to obtain comparable estimates), 
we found that the effect estimates for the missing 
(β=1.22 (95% confidence interval 0.82 to 1.81)) and 
complete case groups (β=1.30 (1.01 to 1.69)) were 
similar with overlapping confidence intervals.
discussion
Principal findings
In this prospective cohort study of pregnant women, we 
found that maternal gluten intake during pregnancy 
was strongly associated with the subsequent risk of 
their offspring developing type 1 diabetes, with risk 
increasing proportionally (hazard ratio 1.31 (95% 
confidence interval 1.001 to 1.72) per 10 g/day increase 
of gluten intake). A twofold risk of offspring developing 
type 1 diabetes was found when comparing mothers 
table 3 | association between maternal gluten intake and offspring type 1 diabetes (n=67 565)
Maternal gluten intake, by  
percentile*
no (%) of cases of type 1 
diabetes in offspring/total
Hazard ratio (95% ci) of type 1 diabetes diagnosis in offspring
unadjusted model adjusted model 1 adjusted model 2
Continuous intake, per 10 g/day 
increse
— 1.28 (1.03 to 1.58) 1.31 (1.002 to 1.72) 1.31 (1.001 to 1.72)
10% 20 (0.30)/6761 1.00 (reference) 1.00 (reference) 1.00 (reference)
10-20% 20 (0.30)/6769 0.99 (0.53 to 1.84) 1.07 (0.57 to 1.99) 1.06 (0.57 to 1.99)
20-50% 69 (0.34)/20 289 1.13 (0.9 to 1.86) 1.32 (0.75 to 2.30) 1.31 (0.75 to 2.30)
50-80% 73 (0.36)/20 268 1.19 (0.73 to 1.96) 1.46 (0.82 to 2.61) 1.46 (0.82 to 2.60)
80-90% 30 (0.44)/6750 1.47 (0.84 to 2.59) 1.82 (0.93 to 3.53) 1.81 (0.93 to 3.53)
≥90% 35 (0.52)/6728 1.72 (0.99 to 2.97) 2.03 (1.02 to 4.01) 2.00 (1.02 to 4.00)
Ptrend — 0.013 0.016 0.016
Adjusted model 1=adjusted for maternal body mass index before pregnancy, age, parity, smoking status, parental socioeconomic status, total energy 
intake, breastfeeding duration, caesarean section, and offspring sex; adjusted model 2=same as model 1 but also adjusted for pre-existing maternal type 2 
diabetes and suspected gestational diabetes mellitus.
*Median intake of gluten in the <10%, 10-20%, 20-50%, 50-80%, and ≥90% percentile categories were 5, 8, 11, 15, 18, and 22 g/day, respectively.
table 2 | Maternal diet of study participants (n=67 565) according to gluten intake. Data are mean (standard deviation)
all partici-
pants 
(n=67 565)
gluten intake by percentile (g/day; median (range))*
<10% (5 
(0-7))
10-20% (8 
(7-9))
20-50% (11 
(9-13))
50-80% (14 
(13-17))
50-80% (18 
(17-20))
≥90% (22 
(20-66))
Total energy intake (mJ/day) 10.1 (0.3) 7.2 (0.2) 8.2 (0.2) 9.2 (0.2) 10.7 (0.2) 11.9 (0.2) 13.6 (0.3)
Protein (E%) 15.7 (2.4) 16.7 (3.0) 16.4 (2.6) 16.0 (2.3) 15.5 (2.3) 15.0 (2.2) 14.6 (2.2)
Carbohydrate (E%) 51.4 (5.8) 50.9 (7.1) 51.5 (5.9) 51.4 (5.6) 51.4 (5.5) 51.4 (5.4) 51.5 (5.7)
Sugar (E%) 8.2 (4.7) 10.2 (6.3) 8.8 (5.2) 8.4 (4.7) 7.8 (4.3) 7.4 (4.0) 7.1 (3.8)
Fibre (E%) 2.2 (0.6) 1.6 (0.5) 2.0 (0.5) 2.1 (0.5) 2.3 (0.5) 2.4 (0.5) 2.4 (0.5)
Fat (E%) 31.4 (6.3) 31.1 (7.1) 30.5 (6.2) 31.0 (6.0) 31.5 (6.2) 31.9 (6.4) 32.3 (6.8)
Monounsaturated fatty acids (E%) 9.9 (2.2) 10.0 (2.5) 9.7 (2.1) 9.8 (2.1) 9.9 (2.2) 10.0 (2.2) 10.0 (2.4)
Polyunsaturated fatty acids (E%) 4.6 (0.9) 4.2 (1.1) 4.4 (0.9) 4.6 (0.9) 4.7 (0.8) 4.9 (0.9) 4.9 (0.9)
Saturated fatty acids (E%) 12.8 (3.5) 13.1 (3.7) 12.6 (3.4) 12.7 (3.3) 12.8 (3.4) 12.9 (3.5) 13.1 (3.7)
Whole grain (g/day) 156 (108) 41 (29) 126 (70) 146 (40) 226 (106) 246 (101) 326 (155)
Refined grain (g/day) 67 (69) 46 (26) 49 (31) 63 (35) 78 (76) 102 (91) 138 (109)
Breakfast cereals (g/day) 25 (45) 25 (42) 30 (46) 26 (45) 24 (43) 16 (43) 13 (39)
E%=percentage of total energy intake.
*All dietary variables presented in the table were significantly correlated (all P<0.001), as measured by Spearman’s r.
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who had the highest versus lowest gluten intakes 
(≥20 v <7 g/day; hazard ratio 2.00 (95% confidence 
interval 1.02 to 4.00)). Our stratified analyses suggest 
that parous, older, or overweight/obese women might 
be more sensitive to gluten intake than those who are 
younger or of normal weight. However, these results 
are at best suggestive, owing to the loss of statistical 
power when stratifying by individual maternal 
characteristics, and more evidence is needed to confirm 
these suggestive trends. Likewise, the mechanism that 
might be responsible for this effect is not known, but 
could include increased inflammation38–41 or increased 
intestinal permeability.42 43
Gluten intake and total calorie intake were correlated 
in our dataset, and high maternal body mass index or 
gestational diabetes is associated with both type 1 
and 2 diabetes in children.44–46 As a result, it could be 
hypothesised that the association observed in our present 
study could have been caused by high body mass index 
rather than by gluten. The involvement of body mass 
index is probably not the case, because we noted that 
high gluten intake inversely correlated with maternal 
body mass index. Thus, if diabetes development was 
triggered by high maternal body mass index, we would 
not observe a dose dependent association of gluten 
intake in the mothers, but rather an inverse effect.
strengths and limitations of study
A major strength of our study was the study design. The 
data were gathered from one of the largest prospective 
birth cohorts, increasing the power in the presented 
associations, and the prospective design eliminated 
recall bias because food frequency questionnaires 
were collected before knowledge of the disease 
outcome. The use of a food frequency questionnaire is 
considered to be a reproducible and valid method to 
assess diet during pregnancy,47 48 and the register used 
to identify children with type 1 diabetes (DanDiabKids) 
is annually validated.27 Furthermore, comprehensive 
registry and interview data collected during and after 
pregnancy made it possible to adjust for a large number 
of confounders and perform sensitivity analyses, 
and our results were robust to adjustment for well 
established predictors of type 1 diabetes in offspring. 
Our use in Denmark of unique ID numbers (from the 
Danish Civil Registration System (CPR)) for every 
citizen enabled a follow-up of our cohort that was near 
100% for identifying incident cases of type 1 diabetes 
in the children through linkage to the DanDiabKids 
register, which has full national coverage.
Despite the large study size, the statistical power of 
our study was still modest because of the low number of 
cases of type 1 diabetes (n=247) in our study population, 
which was reflected by some associations that were 
only just below the threshold set for formal significance 
(α=0.05). In addition, the role of unmeasured or 
unidentified confounders can never be fully excluded 
in observational studies. Confirmation of our findings 
in another comparable but independent dataset is 
therefore warranted. Dietary assessment methods that 
rely on the participants’ ability to report their habitual 
diet are inevitably subject to uncertainties, owing to 
the inherent difficulty in recalling diet accurately. 
However, food frequency questionnaires have proved 
useful for ranking individuals according to quantified 
dietary intake of foods and food constituents in large 
scale epidemiological studies, where the use of precise 
methods such as dietary records are not feasible.49
table 4 | stratified analyses of risk of type 1 diabetes in offspring versus maternal gluten intake during pregnancy, by 
maternal characteristics
Maternal characteristics
no (%) of cases of type  
1 diabetes in offspring/
total no
Hazard ratio (95% ci) of type 1 diabetes diagnosis in 
 offspring per 10 g/day increase of maternal gluten intake
unadjusted model adjusted model
Maternal age 
 <30 years 134 (0.41)/32 461 1.29 (0.97 to 1.72) 1.13 (0.78 to 1.63)
 ≥30 years 113 (0.32)/35 104 1.28 (0.93 to 1.77) 1.57 (1.09 to 2.29)
Parity
 Not parous 120 (0.37)/32 738 1.32 (0.96 to 1.82) 1.15 (0.75 to 1.76)
 Parous 127 (0.36)/34 827 1.24 (0.93 to 1.65) 1.49 (1.06 to 2.09)
Body mass index before pregnancy
 <25 164 (0.34)/45 506 1.34 (1.02 to 1.75) 1.17 (0.82 to 1.65)
 ≥25 83 (0.44)/19 059 1.20 (0.85 to 1.69) 1.68 (1.08 to 2.60)
Maternal diabetes
  No pre-existing diabetes or gestational 
diabetes mellitus
240 (0.36)/66 418 1.24 (1.00 to 1.55) 1.27 (0.96 to 1.68)
  Pre-existing type 2 diabetes or suspected 
gestational diabetes mellitus
7 (0.61)/1147 2.32 (1.18 to 4.57) 2.08 (0.92 to 4.69)
 Type 1 diabetes* 9 (2.71)/332 0.90 (0.31 to 2.67) 0.63 (0.16 to 2.40)
Offspring sex
 Male 132 (0.38)/34 658 1.63 (1.27 to 2.10) 1.41 (1.02 to 1.96)
 Female 115 (0.35)/32 907 0.93 (0.65 to 1.32) 1.19 (0.76 to 1.85)
Offspring age at diagnosis
 ≤10 years 130 (0.44) /67 565 1.25 (0.93 to 1.67) 1.27 (0.88 to 1.82)
 <10 years 117 (0.18) /66 576 1.31 (0.95 to 1.79) 1.36 (0.91 to 2.03)
Adjusted model=adjusted for maternal body mass index before pregnancy, age, parity, smoking status, parental socioeconomic status, total energy, 
breastfeeding duration, pre-existing maternal type 2 diabetes, and suspected gestational diabetes mellitus. When stratifying by age and body mass index, 
these variables were included as covariates in the adjusted model.
*It was decided a priori to exclude these women from our analyses, but the association is reported here under “maternal diabetes” for consistency.
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Although gluten containing foods are easy to 
identify, and the protein fractions of gluten in wheat, 
rye, and barley are known, gluten is also intentionally 
added during production to certain types of flour, 
bread, and other foods, which we were unable to 
account for. This unaccountable addition of gluten 
would lead to a systematic underestimation of intake. 
Also relevant to our intake estimation was that 
statistical associations including essential nutrients 
are commonly examined by transforming crude intake 
to nutrient densities or energy adjusted residuals.37 
The underlying assumption is that the energy intake is 
roughly proportional to the physiological needs of each 
individual, meaning that it is the energy density of the 
nutrient under consideration that in most cases is the 
determinant of health. However, this assumption does 
not hold for non-essential nutrients or other substances 
that might be detrimental in absolute terms. Gluten is 
not an essential nutrient, and studies on gluten and 
type 1 diabetes in laboratory animals suggest that it is 
the absolute amount of gluten that influences the risk 
of type 1 diabetes.4 As a result, we based our analyses 
on the absolute gluten intake. Justifying this approach, 
and despite a strong correlation between absolute 
gluten and total energy intake (table 2), we found no 
indication in our sensitivity analyses to suggest that 
maternal energy intake was related to offspring type 1 
diabetes risk. The same conclusions were reached when 
we used a more traditional way of accounting for energy 
intake, using energy adjusted residuals37 (table S1). 
Another limitation was that we do not know whether 
mothers with a low intake of gluten during pregnancy 
also serve a low gluten diet to their infants. This factor 
could be important for type 1 diabetes development 
because the amount, timing,50–52 and mode of gluten 
introduction all seem to affect disease development.4 
However, in our animal experiments, a gluten free diet 
fed to mothers during pregnancy was far more effective 
in preventing diabetes in the offspring than a gluten 
free diet fed to the offspring,11 suggesting that the 
intrauterine environment could be the decisive factor 
for the development of type 1 diabetes.
comparison with other studies
To our knowledge, only two other studies have looked 
at the association of gluten intake in pregnancy and 
risk of type 1 diabetes in children. In both studies, 
researchers investigated at-risk children (HLA 
conferred susceptibility) and the development of β cell 
autoantibodies. Lamb and colleagues23 investigated a 
cohort of 642 children whose mothers filled out a food 
frequency questionnaire covering the third trimester. Of 
these children, 27 developed autoimmunity. Virtanen 
and colleagues24 studied a cohort of 3723 infants, of 
whom 138 developed autoimmunity and whose mothers 
filled out a food frequency questionnaire postnatally, 
covering the eighth month of pregnancy. These two 
studies did not find an association between maternal 
gluten intake and development of autoantibodies in 
the children. Their findings differ from to our study 
results, and could be explained by multiple differences 
in the design of the two studies: inclusion of high risk 
study populations, use of a postnatally completed 
food frequency questionnaire, different outcomes and 
exposure times, insufficient statistical power, shorter 
follow-up time, or a setup that allowed for adjustment 
for fewer confounders. Thus, statistically well powered 
studies with information on potential confounders and 
evaluating childhood diabetes have currently been 
lacking to firmly establish whether prenatal gluten 
exposure is a risk factor for childhood diabetes.
conclusions and policy implications
The possible effect of maternal gluten intake on risk 
of type 1 diabetes in offspring might be related to the 
complex interplay between diet, immune development, 
microbiota, and intestinal permeability, which could 
all affect the pathogenesis of type 1 diabetes. There are 
regional differences in the effect of probiotics and type 
1 diabetes development as well as in the microbiome 
and structure of gluten and in the gluten content of 
crops. The effect of gluten intake during pregnancy 
could therefore vary geographically. In humans, the 
establishment of the microflora early in life might affect 
children’s risk of chronic immune disorders; babies 
delivered by caesarean section have a 23% increased 
risk of onset of type 1 diabetes in childhood.53
It was previously assumed that fetuses were sterile, 
but evidence suggests that the establishment of the 
fetus microflora could already start in utero, transferred 
from maternal intestinal microbiota.54 The colonisation 
of the child’s intestine continues to develop after 
vaginal birth through contact with vaginal bacteria 
and maternal faeces, and is subsequently affected 
by breastfeeding and early infant feeding. Maternal 
intestinal and vaginal microbiota and the composition 
of breast milk are influenced by maternal diet (eg, gluten 
intake).55 Thus, high gluten intake, as reported during 
pregnancy, could reflect habitual diets that shape the 
maternal, and thus the neonatal, microbiome.
Our study suggests that high gluten intake in 
pregnancy might be a risk factor for type 1 diabetes 
in offspring. The association is moderate, suggesting 
a 50% reduction in type 1 diabetes incidence among 
the children of mothers with the highest versus lowest 
gluten intake. This magnitude is comparable to results 
from other studies looking at other potential protective 
factors (that is, breastfeeding and D3 vitamin 
supplementation) in early childhood.56  57 However, 
more evidence is needed before changes to dietary 
recommendations could be justified. Confirmation is 
warranted, preferably in an intervention setting, or 
in other cohort studies. In this context, the safety of 
substituting gluten containing foods for other foods 
and nutrients should be investigated as well as the 
possibility of obtaining a larger effect by adherence 
to a completely gluten free diet. Whether a diet with 
a low gluten content during pregnancy changes the 
incidence of coeliac disease in children should be 
investigated, although a recent study did not support 
this concern.58
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